Categories: News

Introducing the Gianna Lullume Smart Infant Sleep Device: A Revolutionary Solution for Infant Sleep Now on Kickstarter

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

HONG KONG, Dec. 10, 2024 /PRNewswire/ — The Gianna Lullume Smart Infant Sleep Device, an innovative product developed by Kerchan Group, has officially launched on Kickstarter. This innovative sleep aid for infants boasts cutting-edge technology and a user-friendly interface, quickly gaining interest from parents worldwide. Designed specifically for infants, this smart sleep device leverages advanced features including intelligent cry detection, soothing lights, and sounds to address common sleep challenges, such as nighttime crying, providing better sleep experiences for both babies and parents.

Comprehensive Features for a Comfortable Sleep Environment
The Gianna Lullume Smart Infant Sleep Device combines scientific principles with thoughtful design, offering the following key features:

  1. Intelligent Cry Detection: When a baby’s cry is detected within 10 seconds, the device automatically plays soothing sounds and activates calming lights. If the baby continues to cry for 60 seconds, a notification is sent to the parents’ phone along with an alert sound to ensure they can respond promptly.
  2. Various Soothing Sounds: The device includes a variety of built-in sounds such as white noise, fan sounds, lullabies, nature sounds (e.g., rain and waves), shushing sounds, heartbeat sounds, and womb-like sounds to help babies drift off quickly and peacefully.
  3. Calming Light Design: Equipped with eight different light modes, which supports natural sleep for infants.
  4. Smart Timer Function: Both the lights and sounds can be set to turn off automatically after a preset time, simplifying the bedtime routine for parents.
  5. Remote and Secure Control: Parents can control the device remotely through the companion app and enable a child-lock feature to prevent accidental changes.
  6. Sleep Training Feature: The device uses light cues to help infants develop an awareness of sleep schedules, teaching them when to stay in bed and when to call for their parents, giving parents more rest time.

Simon Shawn, Chairman of Kerchan Group, said, “The inspiration behind Gianna Lullume comes from a father’s love. Through this product, we aim to bring warmth, companionship, and quality sleep to more families Is your baby Sleepless or Restless? No need to worry, you can calm the little one with Gianna Lullume.”

As a revolutionary sleep product, Gianna Lullume not only improves the sleep quality of infants but also uses scientific methods to help babies fall asleep faster and sleep longer. By reducing parents’ sleep-related stress, it fosters true relaxation and happiness for the entire family.

Crowdfunding Now Live: Experience a Smarter Parenting Solution
The Gianna Lullume Smart Infant Sleep Device is now available for crowdfunding on Kickstarter. Parents worldwide can support the project and enjoy exclusive early-bird pricing to experience this innovative product.

Gianna Lullume is more than just a product; it’s a transformative approach to parenting, aimed at delivering care and love to families around the globe.

To learn more and participate in the campaign, visit the Kickstarter platform and join the mission to improve sleep quality for babies, fostering happier family lives.

Gianna Branding Team
brand@kerchangroup.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/introducing-the-gianna-lullume-smart-infant-sleep-device-a-revolutionary-solution-for-infant-sleep-now-on-kickstarter-302327366.html

SOURCE Gianna

Staff

Recent Posts

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable…

2 hours ago

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility…

2 hours ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction…

5 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows

Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and…

5 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift

Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs…

5 hours ago

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits…

5 hours ago